Arvinas Inc (ARVN) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arvinas Inc   (NASDAQ: ARVN)


Arvinas Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Arvinas Inc 's ROA in the second quarter of 2026?
Arvinas Inc achieved a return on average assets (ROA) of 1.29 % in its second quarter of 2026 a new company high.

ROA has improved compared to -28.33% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 197 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3613, from total ROA ranking in the first quarter of 2026 at 3716.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -25.58 % -34.82 % -33.67 % -28.31 % -27.92 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 9 -221 -81 -59 -73
Return On Assets (TTM) 1.29 % -28.33 % -9.31 % -6.1 % -6.97 %
ARVN's Total Ranking # 3613 # 3716 # 3094 # 3142 # 3005
Total Assets (TTM) in million 686 648 718 837 922
Seq. Total Assets Change 6.01 % -9.81 % -14.2 % -9.28 % -7.16 %
Seq. Net Income Change - - - - -

ARVN's 5 Years Annual ROA >> Back to ARVN Management Effectiveness >> Compare ARVN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 68
Sector # 198
Overall # 2041

Return On Assets Statistics
High Average Low
1.29 %
-22.69 %
-42.29 %
(Jun 30 2026)   (Sep 30 2023)





Financial Statements
Arvinas Inc 's Assets $ 686 million ARVN's Balance sheet
Arvinas Inc 's Income $ 169 million Quarterly ARVN's Income Statement
ARVN's Income by Division See ARVN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -33.67 % -16.92 % 3.01 % -19.92 % 84.99 %
Total Assets in million 718 1,082 1,303 1,265 1,579
Y / Y Net Income Change - - - - -
Net Income in million -81 -199 -367 -283 -191
Annual Return On Assets -11.26 % -18.38 % -28.2 % -22.34 % -12.09 %

ARVN's 5 Years Annual ROA >> Back to ARVN Management Effectiveness >> Compare ARVN ROA to its Competitors



More Return On Assets Ratios
ARVN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ARVN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ARVN's Competitors
Subscribers only: Roa for Arvinas Inc 's Suppliers
Subscribers only: Return On Assets for ARVN's Customers

You may also want to know
ARVN's Roi ARVN's Inventory Turnover Ratio ARVN's Growth Rates ARVN's Dividend Comparisons
ARVN's Profitability Ratios ARVN's Asset Turnover Ratio ARVN's Dividend Growth
ARVN's Roe ARVN's Valuation Ratios ARVN's Financial Strength Ratios ARVN's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %

Date modified: 2026-09-26T07:34:42+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.